Zhejiang Hisun Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Zhejiang Hisun Pharmaceutical Co Ltd cash flow reinvestment rate. Zhejiang Hisun Pharmaceutical Co Ltd (600267) has a Cash Flow Reinvestment Rate of 0.23x as of September 2025, reinvesting CN¥102.69 Million (capex CN¥102.69 Million ) from operating cash flow of CN¥438.43 Million. Explore 600267 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Zhejiang Hisun Pharmaceutical Co Ltd (1999–2025)
Cash flow reinvestment rate of Zhejiang Hisun Pharmaceutical Co Ltd from 1999 to 2025. Historical reinvestment intensity for Zhejiang Hisun Pharmaceutical Co Ltd across 27 annual periods. Explore reinvestment intensity of Zhejiang Hisun Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Zhejiang Hisun Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (1999–2025)
Zhejiang Hisun Pharmaceutical Co Ltd cash flow reinvestment rate by year from 1999 to 2025. Year-by-year capital reinvestment analysis for Zhejiang Hisun Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 600267 cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.22x | CN¥443.14 Million | CN¥2.03 Billion | CN¥376.40 Million | ▲ +76.9% |
| 2024 | 0.12x | CN¥260.70 Million | CN¥2.11 Billion | CN¥238.44 Million | ▼ -67.7% |
| 2023 | 0.38x | CN¥578.74 Million | CN¥1.52 Billion | CN¥240.04 Million | ▼ -29.0% |
| 2022 | 0.54x | CN¥1.11 Billion | CN¥2.07 Billion | CN¥530.62 Million | ▲ +29.1% |
| 2021 | 0.42x | CN¥722.31 Million | CN¥1.74 Billion | CN¥622.38 Million | ▼ -64.7% |
| 2020 | 1.18x | CN¥1.87 Billion | CN¥1.59 Billion | CN¥692.04 Million | ▼ -25.1% |
| 2019 | 1.57x | CN¥1.10 Billion | CN¥698.39 Million | CN¥1.08 Billion | ▲ +22.1% |
| 2018 | 1.29x | CN¥1.86 Billion | CN¥1.45 Billion | CN¥1.60 Billion | ▲ +3.5% |
| 2017 | 1.25x | CN¥1.54 Billion | CN¥1.24 Billion | CN¥1.46 Billion | ▼ -67.9% |
| 2016 | 3.88x | CN¥3.01 Billion | CN¥775.90 Million | CN¥1.77 Billion | ▲ +23.6% |
| 2015 | 3.14x | CN¥2.31 Billion | CN¥736.17 Million | CN¥1.93 Billion | ▼ -17.0% |
| 2014 | 3.78x | CN¥2.16 Billion | CN¥571.04 Million | CN¥2.16 Billion | ▼ -6.1% |
| 2013 | 4.02x | CN¥2.12 Billion | CN¥527.25 Million | CN¥2.12 Billion | ▼ -7.4% |
| 2012 | 4.34x | CN¥1.63 Billion | CN¥375.75 Million | CN¥1.63 Billion | ▲ +76.4% |
| 2011 | 2.46x | CN¥1.29 Billion | CN¥525.31 Million | CN¥1.29 Billion | ▲ +52.4% |
| 2010 | 1.62x | CN¥823.08 Million | CN¥509.18 Million | CN¥823.08 Million | ▼ -11.3% |
| 2009 | 1.82x | CN¥861.67 Million | CN¥472.85 Million | CN¥861.67 Million | ▼ -37.8% |
| 2008 | 2.93x | CN¥648.25 Million | CN¥221.28 Million | CN¥648.25 Million | ▲ +309.2% |
| 2007 | 0.72x | CN¥313.34 Million | CN¥437.72 Million | CN¥313.34 Million | ▼ -75.5% |
| 2006 | 2.92x | CN¥315.67 Million | CN¥108.03 Million | CN¥315.67 Million | ▲ +23.4% |
| 2005 | 2.37x | CN¥268.75 Million | CN¥113.53 Million | CN¥268.75 Million | ▲ +137.0% |
| 2004 | 1.00x | CN¥312.52 Million | CN¥312.93 Million | CN¥312.52 Million | ▲ +13.5% |
| 2003 | 0.88x | CN¥253.90 Million | CN¥288.45 Million | CN¥253.90 Million | ▼ -56.3% |
| 2002 | 2.01x | CN¥243.39 Million | CN¥120.82 Million | CN¥243.39 Million | ▼ -47.5% |
| 2001 | 3.84x | CN¥265.33 Million | CN¥69.14 Million | CN¥265.33 Million | ▲ +5.4% |
| 2000 | 3.64x | CN¥202.76 Million | CN¥55.70 Million | CN¥202.76 Million | ▼ -0.3% |
| 1999 | 3.65x | CN¥119.23 Million | CN¥32.64 Million | CN¥119.23 Million | — |